Alerts will be sent to your verified email
Verify Email
KPL
|
Kwality Pharma
|
Venus Remedies
|
Lincoln Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
25.27 % | 8.87 % | 15.1 % |
|
5yr average Equity Multiplier
|
1.96 | 1.32 | 1.26 |
|
5yr Average Asset Turnover Ratio
|
1.05 | 0.96 | 0.82 |
|
5yr Avg Net Profit Margin
|
11.66 % | 6.91 % | 14.59 % |
|
Price to Book
|
3.67 | 1.74 | 1.35 |
|
P/E
|
21.71 | 14.68 | 12.09 |
|
5yr Avg Cash Conversion Cycle
|
55.02 Days | 46.96 Days | -6.41 Days |
|
Inventory Days
|
67.04 Days | 75.64 Days | 43.91 Days |
|
Days Receivable
|
132.46 Days | 54.28 Days | 91.75 Days |
|
Days Payable
|
126.93 Days | 58.86 Days | 128.38 Days |
|
5yr Average Interest Coverage Ratio
|
16.13 | 396.11 | 63.13 |
|
5yr Avg ROCE
|
34.73 % | 8.42 % | 19.81 % |
|
5yr Avg Operating Profit Margin
|
23.23 % | 10.14 % | 18.35 % |
|
5 yr average Debt to Equity
|
0.46 | 0.08 | 0.0 |
|
5yr CAGR Net Profit
|
21.34 % | -6.01 % | 5.76 % |
|
5yr Average Return on Assets
|
12.96 % | 6.69 % | 11.92 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
54.83 % | 41.76 % | 49.78 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.38 % | 0.0 | 5.7 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Kwality Pharma
|
Venus Remedies
|
Lincoln Pharma
|
|
|---|---|---|---|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Formulations Breakup
|
Formulations Breakup
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|